Flagship release. Janoshik Analytical tested this batch on 4 November 2025 at 99.262% HPLC. It documents the 300-click Retatrutide 30mg pen format (0.1 mg per click).
Related context: the six documented Retatrutide formats in the UAE, the Retatrutide pen guide, and the Janoshik verification walkthrough.
Batch Facts
- Product
- Retatrutide 30mg Pen (flagship release)
- Batch number
- RETP002
- Molecule
- Retatrutide (LY-3437943), CAS 2381089-83-2
- Purity (HPLC)
- 99.262%
- Test method
- HPLC (High-Performance Liquid Chromatography)
- Laboratory
- Janoshik Analytical
- Analysis date
- 4 November 2025
- Report (PDF)
- janoshik-analytical-coa.pdf
- Report (image)
- remediumtestresults.webp
Janoshik Report
Full HPLC purity report from Janoshik Analytical.
What This Test Proves
Janoshik tested peptide identity and chromatographic purity for batch RETP002. The result confirms the active compound is retatrutide and the HPLC trace is 99.262% pure.
What it does not prove: assay strength (mg per click), bacterial endotoxin, heavy-metal content, residual solvents, sterility, or shelf life beyond the test date. The 30mg Pen format carries a manufacturer specification of 0.1 mg per click across 300 clicks; that figure is not verified by this report.